Loading song details...
AGDD 2024 D1S16 Closing Remarks From Day One
No description available.
MP3 Download
Video Download
Related Songs
5:24
AGDD 2024 D1S16 Closing Remarks From Day One
18:42
AGDD 2024 D1S16 Q A Discussion Panel 4
15:29
AGDD 2024 D1S11 Orally Inhaled Drug Product PSGs Considerations For Using Modeling And Sim
9:20
AGDD 2024 D2S10 1 Analysis Of First Cycle BE Adequacy And Major Deficiencies Encountered
16:14
AGDD 2024 D1S02 IVRT Methods For In Situ Depot Forming Long Acting Injectable Products
22:07
AGDD 2024 D2S06 Emerging Generic Oligonucleotides Challenges And Progress
22:02
AGDD 2024 D2S11 ICH M13A First Guideline For Bioequivalence
17:12
AGDD 2024 D1S07 Enhanced Understanding Of Structure Performance Relationship Using Modeling
17:29
AGDD 2024 D1S01 Keynote Address
29:19
AGDD 2024 D2S07 The Journey Of First Approvals Complex Generic Long Acting Injectable Products
21:59
AGDD 2024 D2S02 Quality Considerations For First Generic Oral Liquids
15:26
AGDD 2024 D2S12 Model Integrated Evidence MIE Industry Meeting Pilot Program For Generic
12:28
AGDD 2024 D1S15 Approaches To Analyzing Comparative Use Human Factors Studies
7:07
AGDD 2024 D2S14 Closing Remarks
22:53
AGDD 2024 D1S10 Orally Inhaled Drug Product PSGs General Considerations Using The Alternative
14:39
AGDD 2024 D1S06 Current Trends In Product Specific Guidance PSG Development Revisions For
22:47
AGDD 2024 D1S14 Drug Device Combination Products A New Methodology For Evaluation
20:42
AGDD 2024 D1S09 Q A Discussion Panel 2
19:26
AGDD 2024 D1S13 Q A Discussion Panel 3
22:50